Pathology report generation

Benchmarks

Dataset Name	SOTA Method	Metric
PathText BRCA (test)	RANGER	BLEU-10.4598	32	4mo ago
REG 2025 (test Phase 2)		Overall Score0.8494	15	5mo ago
ML-Path Mean (test)	PriOrGen	BLEU0.273	9	23d ago
ML-Path DLBC (test)	BiGen	BLEU Score23	9	23d ago
ML-Path CHOL (test)	PriOrGen	BLEU Score21.3	9	23d ago
ML-Path ACC (test)	R2Gen	BLEU22.2	9	23d ago
ML-Path MESO (test)	PriOrGen	BLEU20.3	9	23d ago
ML-Path LIHC (test)	Transformer	BLEU Score24.7	9	23d ago
ML-Path STAD (test)	PriOrGen	BLEU Score (Mean)0.279	9	23d ago
ML-Path COAD (test)	PriOrGen	BLEU Score (Mean)0.259	9	23d ago
ML-Path THCA (test)	PriOrGen	BLEU0.286	9	23d ago
ML-Path KIDNEY (test)	PriOrGen	BLEU Score (Mean)32.4	9	23d ago
ML-Path LUNG (test)	PriOrGen	BLEU Score26.9	9	23d ago
ML-Path BRCA (test)	PriOrGen	BLEU Score25	9	23d ago
Multi-organ pathology dataset (test)	MR-ViT	BLEU-10.5507	9	5mo ago
HistAI	Stage 2 baseline	Ours Favored Count460	3	1mo ago
HistGen overlapping skin cases subset of 67		Diagnostic Consistency (mean/3)0.85	2	1mo ago
Melanocytic Lesion Reader Study Other lesions, N=25 (test)	-	-	0	5mo ago
Melanocytic Lesion Reader Study Common nevi N=25 (test)	-	-	0	5mo ago
Melanocytic Lesion Reader Study All cases, N=50 (test)	-	-	0	5mo ago

Showing 20 of 20 rows